NR2F1 and breast cancer: We used two primary breast cancer single-cell sequencing cohorts, Cohort 1 and 2 [46,47], where 5.1% and 2.7% of cancer cells excluding the other cell types expressed any NR2F1 mRNA (NR2F1-positive group), respectively.